CaliberMRI Featured in QIBA Newsletter

Nov 25, 2022 | CMRI in the News

CaliberMRI was published in the Quantitative Imaging Biomarkers Alliance’s (QIBA) February newsletter. Our Director of Business Development, Kevin Miller, discussed how CaliberMRI’s imaging phantoms and quality control (QC) automation software, qCal-MR®, are being used by the quantitative MRI community to standardize scanners and improve confidence in treatment monitoring and diagnostics.

QIBA leadership recognized the relevance of the new commercial platform to the MRI DW committee’s efforts and established that validation of qCalMR with respect to the Profile and the UM analysis tools and establishment of CaliberMRI as a scanner QC analysis service provider could yield a sustainable process for accelerating the adaptation of the DWI Profile in the medical imaging community. To that end, during 2021, qCal-MR was rigorously evaluated against UM benchmark cases. These baseline DICOMs, generated using scanners from Philips, GE, and Siemens at different sites with various staff members, provide a repeatable basis for validation and verification.

Related Articles

CaliberMRI Receives State Grant for Biomimetic Quantitative MRI Development

Boulder, Colorado — CaliberMRI is honored to announce it has been awarded an Early-Stage  Capital and Retention grant through the Colorado Office of Economic Development and International Trade (OEDIT) Advanced Industries Accelerator program. This funding will help further quantitative Magnetic Resonance Imaging (qMRI) through the development of biomimetic phantoms for use in breast cancer treatment and therapy monitoring. […]